New therapeutic uses of peptides of the adipokinetic hormone family

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F19%3A43920129" target="_blank" >RIV/00023752:_____/19:43920129 - isvavai.cz</a>

Result on the web

<a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=EP238115837&tab=NATIONALBIBLIO" target="_blank" >https://patentscope.wipo.int/search/en/detail.jsf?docId=EP238115837&tab=NATIONALBIBLIO</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

New therapeutic uses of peptides of the adipokinetic hormone family

Original language description

The present invention is related to a new use of adipokinetic hormone/red pigment-concentrating hormone (AKH/RPCH) family of peptides. The invention particularly relates to adipokinetic hormone/red pigment-concentrating hormone (AKH/RPCH) family of peptides for use in the treatment of a disease selected from the group consisting of schizophrenia, psychosis, obsessive-compulsive disorder, attention deficiency hyperactivity syndrome, mania and bipolar disorder

Czech name

—

Czech description

—

Type

P - Patent

CEP classification

—

OECD FORD branch

30210 - Clinical neurology

Project

Result was created during the realization of more than one project. More information in the Projects tab.

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2019

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Patent/design ID

EP3446753

Publisher

EPO_1 -

Publisher name

European Patent Office

Place of publication

Munich, The Hague, Berlin, Vienna, Brussels

Publication country

—

Date of acceptance

Feb 27, 2019

Owner name

Národní ústav duševního zdraví, Topolová 748, 250 67 Klecany

Method of use

B - Výsledek je využíván orgány státní nebo veřejné správy

Usage type

A - K využití výsledku jiným subjektem je vždy nutné nabytí licence